爱尔眼科 (300015)

Aier Eye Hospital Group Co.,Ltd.

ASZ

Tags

300ESG Index300 Non-Cyclical IndexDeepSeekMSCI China A 50 IndexMSCI Component StocksCSI 100 IndexCSI A100 IndexCSI Leading Enterprises IndexVenture Capital ConceptNorthbound Heavy PositionsMedical ServicesMedical Aesthetics ConceptPharmaceuticals and HealthcareHealthGuozheng Infrastructure IndexGuozheng Growth IndexGuozheng Services IndexGuozheng Corporate Governance IndexFund Heavy PositionsLarge Cap GrowthLarge Cap StocksEmerging Markets IndexSmart HealthcarePrivate Enterprises 100 IndexPrivate HospitalsNon-Cyclical StocksChiNext Large CapChiNext 50 IndexChiNext IndexChiNext Blue ChipChiNext HealthcareShenzhen ConnectSZSE 100 IndexSZSE 300 IndexSZSE Growth IndexSZSE Governance IndexCSFC HoldingsPharma & BiotechSZSE Defensive 50 IndexConsumer Services IndexSZSE Medicine Equal Weight IndexBrand Engineering IndexSZSE 100 Equal Weight IndexYangtze River Protection IndexEqual Weight 90 IndexZhongchuang Equal Weight IndexCSI Emerging Industries IndexJuchao Large-cap IndexShenzhen A-Share Pharmaceutical IndexBOC International CSI 300 ESG IndexJuchao 100 IndexChiNext Equal Weight IndexCSI 100 Low Volatility IndexCSI All-share Pharmaceutical Sector IndexSZSE Emerging Industries IndexZhongchuang Growth IndexSZSE 300 Return IndexCSSW Health IndexCSI 1000 Growth IndexSZSE Component Index ReturnCSI 300 Equal Weight IndexCSI 300 ESG IndexLarge & Mid-cap IndexShanghai-Hong Kong-Shenzhen 300 IndexCNI 1000 IndexXingyin Wealth Management Balanced 300 IndexCR Foundation IndexCSSW Silk Road IndexCSI Medical IndexSZSE Performance IndexChiNext Value IndexCSI 300 Quality Low Volatility IndexRestructuringFTSE Russell ConceptLarge-cap Blue-chipJune 2022 Lock-up ExpiryVenture CapitalMedical AestheticsCSI 300 Non-cyclical IndexCNI Emerging Industries IndexPension Industry IndexSZSE Responsibility IndexCNI Responsibility IndexCSI 300 Shenzhen Market IndexZhongchuang 100 Return IndexCSI Super-large Cap IndexSZSE Leaders IndexCSI 300 ESG Leading IndexSZSE 100 Return IndexSZSE High Beta IndexSZSE ChiNext 100 IndexSustainable Development IndexCSI 300 Growth IndexSZSE Pharmaceutical IndexCSI 800 IndexCS Pharmaceutical TI Index100 Performance IndexESG 100 IndexCSI 300 Preferred IndexCNI Pharmaceutical IndexCSI 1000 Pharmaceutical IndexCNI 300 IndexCCTV 500 IndexCSI 300 USD (CNH) IndexChiNext Basic IndexSZSE Private Enterprises IndexCS Pharmaceutical Innovation IndexSZSE Component Pharmaceutical IndexSZSE Low Volatility IndexCSI All-share Pharmaceutical IndexCSI 300 USD IndexSZSE Pharmaceutical 50 IndexSZSE 300 Equal Weight IndexChiNext Low Volatility IndexSZSE Component Index Equal WeightCNI A50 IndexPharmaceutical & Health 100 IndexCSI 300 Pharmaceutical IndexAH Economic Blue-chip IndexSZSE Fundamental 200 IndexPharmaceutical 50 IndexZhongchuang High Beta IndexZhongchuang Low Volatility IndexPharmaceutical 50 Strategy IndexYangtze River 100 IndexChiNext High Beta IndexChiNext Growth IndexESG 300 IndexOrient Securities Competition IndexChina Economic Index GDPChiNext Return IndexCS Internet Medical IndexSZSE Fundamental 120 IndexChiNext Emerging IndexFundamental 600 IndexCSI 300 Growth Innovation IndexChiNext Growth IndexHunan 50 IndexPerformance IndexStrategic Emerging Industries 100 IndexHunan

K-Line Chart

No K-line data available

Company NameAier Eye Hospital Group Co., Ltd.
Listing Date2009-10-30
Issue Price28RMB
Registered Capital932539.66710k RMB
Legal RepresentativeChen Bang
Registered AddressAier Building, No. 188, Section 1, Furong South Road, Tianxin District, Changsha City, Hunan Province
IndustryMedical Services
Main BusinessProviding patients with ophthalmic medical services such as diagnosis and treatment of various eye diseases, as well as medical optometry and eyeglass dispensing.
Company ProfileAier Eye Hospital Group is the first medical institution in China to be listed via an IPO and is also one of the largest ophthalmic medical institutions in China. The group's headquarters is located in Changsha City, Hunan Province. It has currently established over 20 professional eye hospitals nationwide. Aier Eye is committed to introducing world-class ophthalmic technologies and management methods. With a development strategy focused on specialization, scale, and scientific management, it collaborates with domestic and international strategic partners to jointly promote the development of China's ophthalmic medical industry.

Stock Details

1. Key Indicators

  • Total Shares(W): 932539.67
  • Circulating A-Shares(W): 795535.79
  • Earnings Per Share(RMB): 0.3370
  • Net Assets Per Share(RMB): 2.4057
  • Operating Revenue(W RMB): 1748385.85
  • Total Profit(W RMB): 403951.19
  • Net Profit Attributable to Parent(W RMB): 311474.04
  • Net Profit Growth Rate(%): -9.76
  • Weighted Return on Equity(%): 14.3200
  • Operating Cash Flow Per Share(RMB): 0.5450
  • Undistributed Profit Per Share(RMB): 1.2822
  • Capital Reserve Per Share(RMB): 0.0892

2. Main Business

The main business covers:

  • Diagnosis and treatment of various ophthalmic diseases
  • Surgical services
  • Medical optometry and glasses fitting

3. Company Basic Information

  • Company Name: Aier Eye Hospital Group Co., Ltd.
  • Listing Date: 2009-10-30
  • Industry: Medical and Pharmaceutical - Medical Services
  • Address: No. 188 Aier Building, Section 1, Furong South Road, Tianxin District, Changsha City, Hunan Province
  • Website: www.aierchina.com
  • Company Profile: The company's predecessor was Changsha Aier Eye Hospital Co., Ltd., established on January 24, 2003. On December 5, 2007, after registration with the Hunan Provincial Administration for Industry and Commerce, the company was transformed into a joint stock limited company with a registered capital of 100 million yuan and Mr. Chen Bang as the legal representative.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Aier Medical Investment Group Co., Ltd. General Legal Person 320232.36 40.38
2 Hong Kong Securities Clearing Company Ltd. Northbound Funds 16324.96 2.06
3 Huabao CSI Medical ETF Fund 13198.52 1.66
4 E Fund ChiNext ETF Fund 9265.31 1.17
5 Huatai-PineBridge CSI 300 ETF Fund 7944.17 1.00
6 E Fund CSI 300 Healthcare ETF Fund 5845.98 0.74
7 Zhejiang Feike Enterprise Management Co., Ltd. General Legal Person 5788.30 0.73
8 GF CSI All Share Healthcare ETF Fund 1276.28 0.16
9 Guotai CSI Medical ETF Fund 1035.72 0.13
10 GF CSI Medical ETF Fund 824.67 0.10

5. Concept Sectors

  • Venture Capital Concept
  • Smart Wearables
  • Elderly Care Concept
  • Private Hospitals
  • Smart Healthcare
  • Artificial Intelligence
  • Medical Aesthetics Concept
  • DeepSeek
  • Margin Trading
  • Large-Cap Stocks
  • Fund Heavy Holdings
  • MSCI Constituent
  • Northbound Heavy Holdings
  • Non-Cyclical Stocks
  • CSI 100
  • Galaxy 99
  • ChiNext 100
  • Large-Cap Growth
  • ChiNext Index
  • SZSE 100
  • SZSE 300
  • SZSE Governance
  • Consumption 100
  • SZSE Service
  • SZSE Governance
  • SZSE Infrastructure
  • SZSE Growth
  • SZSE Growth
  • CSI 300
  • ChiNext 50
  • ChiNext 300
  • 300 Non-Cyclical
  • CSI Leaders
  • ChiNext Blue Chips
  • ChiNext Large Cap
  • ChiNext Medicine
  • 300 ESG
  • MSCI China A 50
  • Emerging Composite Index
  • SZSE 50
  • CSI A 50
  • CSI A 100

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information